Bulls and bears: the stock market and clinical pathology research.
OBJECTIVE
To analyse the level of funded research in clinical pathology in a recent bear and bull market to act as a predictor for future funding during the current global financial crisis.


METHODS
The level of funding for research published in three clinical pathology journals in 2005 and 2008 to coincide with the bear market of March 2000 to October 2002 and with the subsequent bull market to October 2007 was determined using a Medline query. Other parameters examined were the type of article, affiliation of the first author and the pathology subspecialty.


RESULTS
Approximately 30% of publications were funded and did not differ between the 2 years studied. Original research papers were more likely to be funded than case reports or reviews. Research from university departments of pathology was more likely to be funded than from hospital pathology departments but there were more publications from hospital pathology departments. The proportion of research in the different subspecialties that was funded did not differ significantly between each other and between 2005 and 2008.


CONCLUSIONS
Based on data from the previous bear market, which was the longest and deepest of the post 1950 era, and the subsequent bull market, which led to the all-time high in the Dow Jones Industrial Index, funding for clinical pathology research does not seem to be affected by bull or bear markets.
Khong
T Y
TY
SA Pathology, Women's and Children's Hospital, North Adelaide, Australia. yee.khong@adelaide.edu.au
D015706:Bibliometrics; D035843:Biomedical Research / Q000191:economics* / Q000639:trends; D006801:Humans; D010338:Pathology, Clinical / Q000191:economics / Q000639:trends*; D010506:Periodicals as Topic / Q000706:statistics & numerical data*; D012109:Research Support as Topic / Q000191:economics / Q000706:statistics & numerical data / Q000639:trends*